Aquestive Chief Legal Officer Disposes of $167K in Stock While Receiving Restricted Shares and Options
Aquestive Therapeutics executive transactions filed with the SEC show Chief Legal Officer Lori J. Braender sold roughly $167,345 of common stock on March 10, 2026, while the prior day she received restricted shares and non-qualified options. The company reported a larger-than-expected fourth-quarter 2025 loss and is pursuing an NDA re-submission fo…